ATE533764T1 - Verfahren zur herstellung von solifenacin - Google Patents

Verfahren zur herstellung von solifenacin

Info

Publication number
ATE533764T1
ATE533764T1 AT07855994T AT07855994T ATE533764T1 AT E533764 T1 ATE533764 T1 AT E533764T1 AT 07855994 T AT07855994 T AT 07855994T AT 07855994 T AT07855994 T AT 07855994T AT E533764 T1 ATE533764 T1 AT E533764T1
Authority
AT
Austria
Prior art keywords
solifenacin
pharmaceutically acceptable
base
hydrogen tartrate
transformed
Prior art date
Application number
AT07855994T
Other languages
English (en)
Inventor
Josef Jirman
Richard Junek
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Application granted granted Critical
Publication of ATE533764T1 publication Critical patent/ATE533764T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
AT07855994T 2006-12-22 2007-12-21 Verfahren zur herstellung von solifenacin ATE533764T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060828A CZ300692B6 (cs) 2006-12-22 2006-12-22 Zpusob prípravy solifenacinu
PCT/CZ2007/000119 WO2008077357A2 (en) 2006-12-22 2007-12-21 A method for the preparation of solifenacin

Publications (1)

Publication Number Publication Date
ATE533764T1 true ATE533764T1 (de) 2011-12-15

Family

ID=39327062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07855994T ATE533764T1 (de) 2006-12-22 2007-12-21 Verfahren zur herstellung von solifenacin

Country Status (9)

Country Link
US (1) US20100145055A1 (de)
EP (1) EP2094693B1 (de)
AT (1) ATE533764T1 (de)
CZ (1) CZ300692B6 (de)
EA (1) EA015365B1 (de)
ES (1) ES2375668T3 (de)
PL (1) PL2094693T3 (de)
UA (1) UA96974C2 (de)
WO (1) WO2008077357A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2229387A1 (de) 2007-12-04 2010-09-22 Cadila Healthcare Limited Verfahren zur herstellung einer chemisch und chiral reinen solifenacinbase und ihrer salze
PL3067353T3 (pl) 2008-07-29 2018-04-30 Krka, D.D., Novo Mesto Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania
CA2804107A1 (en) 2010-07-05 2012-01-12 Crystal Pharma S.A.U. Solifenacin salts
CN102887894A (zh) * 2011-07-18 2013-01-23 天津市医药集团技术发展有限公司 一种琥珀酸索利那新晶型及其制备方法
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
EP3753923A1 (de) 2019-06-19 2020-12-23 GH Research Limited Umkristallisierung von 5-methoxy-n,n-dimethyltryptamin (5-meo-dmt) in methyl tert.-butyl ether (mtbe) ohne zugabe eines antilösungsmittels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108992A (en) * 1976-03-10 1977-09-12 Meiji Seika Kaisha Ltd Purification of cefalexin
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
US20080287680A1 (en) * 2004-02-09 2008-11-20 Astellas Pharma Inc. Solifenacin Succinate-Containing Composition
WO2005087231A1 (ja) * 2004-03-16 2005-09-22 Astellas Pharma Inc. ソリフェナシン含有組成物
JP3701964B1 (ja) * 2005-03-08 2005-10-05 アステラス製薬株式会社 キヌクリジン誘導体の新規な塩

Also Published As

Publication number Publication date
UA96974C2 (ru) 2011-12-26
CZ2006828A3 (cs) 2008-07-02
EA200900744A1 (ru) 2009-12-30
EP2094693B1 (de) 2011-11-16
CZ300692B6 (cs) 2009-07-15
ES2375668T3 (es) 2012-03-05
WO2008077357A3 (en) 2008-08-14
WO2008077357A2 (en) 2008-07-03
EA015365B1 (ru) 2011-06-30
PL2094693T3 (pl) 2012-04-30
EP2094693A2 (de) 2009-09-02
US20100145055A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
ATE533764T1 (de) Verfahren zur herstellung von solifenacin
NZ592827A (en) Methods of preparing quinoline derivatives
MY174776A (en) Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
NZ739757A (en) Processes for preparing jak inhibitors and related intermediate compounds
AR059916A1 (es) Procesos y productos intermedios para preparar compuestos esterico
ATE453622T1 (de) Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
BRPI0812625A2 (pt) processo para preparar um sal de cis-atracúrio
NZ599342A (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
AR059296A1 (es) Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona.
ATE554086T1 (de) Scopin-salze und deren verwendung in verfahren zur herstellung von n-demethyl-tiotropium und tiotropiumbromid
KR970703342A (ko) 아자비시클릭 유도체의 제조 방법(Process for The Preparation of Azabicyclic Derivatives)
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE529408T1 (de) Verfahren zur herstellung eines vorläufers von montelukast
UA94614C2 (en) Process for the preparation of solifenacin
ATE473955T1 (de) Verfahren zur herstellung von angereichertem isopulegol
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
WO2008090819A1 (ja) 二環性プロリン化合物の製造方法
ATE514702T1 (de) Verfahren zur herstellung von clopidogrel und dabei verwendete zwischenprodukte
ATE533758T1 (de) Verfahren zur herstellung von enantiomerenreinem esomeprazol
ATE489367T1 (de) Verfahren und zwischenprodukt zur herstellung von donezepil
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
MX2007011274A (es) Procesos y metodos para la preparacion de cis-2-hidroximetil-4-(ci tosin-1-il)-1,3-oxatiolano opticamente activas o sales aceptables farmaceuticamente del mismo.
ATE489385T1 (de) Verfahren zur herstellung von imidazopyridinen
ATE365739T1 (de) Verfahren zur herstellung optisch aktiver 3- chinuclidinole